reports
Target Corp: 1 director
A director at Target Corp sold 45,000 shares at 167.523USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- Dave Nicoski
- Ross LaDuke
RGLD ROYAL GOLD INC
DPZ DOMINO'S PIZZA INC.
TRIP TRIPADVISOR INC.
PODD INSULET CORPORATION
PENN PENN NATIONAL GAMING INC.
OMI OWENS & MINOR INC.
NG. NOVAGOLD RESOURCES INC.
MYGN MYRIAD GENETICS INC.
MNRO MONRO INC
M MACY'S INC
KHC KRAFT HEINZ COMPANY
GCO GENESCO INC.
EMN EASTMAN CHEMICAL COMPANY
EDIT EDITAS MEDICINE INC.
ANIK ANIKA THERAPEUTICS INC.
UFCS UNITED FIRE GROUP INC.
AXP 11 88 0 SOLUTIONS AG
UA AMERICAN EXPRESS COMPANY
TGT UNDER ARMOUR INC. CLASS C
ALCO TARGET CORPORATION
VMD ALICO INC.
PNTG VIEMED HEALTHCARE
TWST PENNANT GROUP
ALXO TWIST BIOSCIENCE
CG ALX ONCOLOGY HOLDINGS
CLSK CARLYLE GROUP INC
BEAM CLEANSPARK
XMTR BEAM THERAPEUTICS
VSCO XOMETRY INC
EMBC VICTORIA'S SECRET & CO
VH EMBECTA CORP
VASTRA HAMNEN CORPORATE FINANCE AB
- MarketLine Department
Abercrombie & Fitch Co - Strategy, SWOT and Corporate Finance Report
Summary Abercrombie & Fitch Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Abercrombie & Fitch Co (Abercrombie) is a specialty retailer that offers a wide range of apparel, accessories, and personal care products. The company’s product portfolio comprises acti...
- Aarti Magan
- Moritz Steinbauer
- Vikas Munjal
Bed, Bath & Beyond Inc. Throws in the Towel—Key Business Risk Weakness...
In this commentary we discuss the business risk weaknesses that led to Bed, Bath & Beyond Inc.’s (BB&B; not rated by DBRS Morningstar) downfall and how these weaknesses can be indicators for which retailers are at increased risk of experiencing a similar fate. Key Business Risk Weaknesses To Watch: (1) Lack of omnichannel capabilities; (2) Unmitigated category concentration; (3) Lack of long-term customer loyalty; and (4) Lack of continuous reinvesting in the business. “BB&B’s demise was prim...
- Dave Nicoski
- Ross LaDuke
TUP TUPPERWARE BRANDS CORPORATION
ATNI ATN INTERNATIONAL INC.
ABM ABM INDUSTRIES INCORPORATED
WETF WISDOMTREE INVESTMENTS INC.
VZ VERIZON COMMUNICATIONS INC.
SLP SIMULATIONS PLUS
SAFM SANDERSON FARMS INC.
OLLI OLLIE'S BARGAIN OUTLET HOLDINGS INC
NBIX NEUROCRINE BIOSCIENCES INC.
K KELLOGG COMPANY
JWN NORDSTROM INC.
HII HUNTINGTON INGALLS INDUSTRIES INC.
HALO HALOZYME THERAPEUTICS INC.
FLT FLEETCOR TECHNOLOGIES INC.
ENV ENVESTNET INC.
CRY CRYOLIFE INC.
AES AES CORPORATION
FF FUTUREFUEL CORP.
CAT CATERPILLAR INC.
ROST ROSINTER RESTAURANTS HOLDING ORD SHS
ADC AGREE REALTY CORPORATION
MSM MSC INDUSTRIAL DIRECT CO. INC. CLASS A
TWTR TWITTER INC.
USPH U.S. PHYSICAL THERAPY INC.
LW LAMB WESTON HOLDINGS INC.
TGT TARGET CORPORATION
WRK WESTROCK COMPANY
DBI DESIGNER BRANDS INC. CLASS A
ASO ACADEMY SPORTS AND OUTDOORS
HOYE HONYE FINANCIAL SERVICES LTD
Moody's changes Target's outlook to positive; affirms A2 long term rat...
Rating Action: Moody's changes Target's outlook to positive; affirms A2 long term rating. Global Credit Research- 29 Mar 2022. New York, March 29, 2022-- Moody's Investors Service today changed the outlook for Target Corporation. to positive from stable and affirmed all other ratings including the A2 long-term and Prime 1 short-term ratings.
A double requalification allows TARGET to improve to Slightly Positive
TARGET (US), a company active in the Broadline Retailers industry, has received a double requalification by the independent financial analyst theScreener. Its fundamental valuation is now 2 out of 4 stars while its market behaviour can be considered as defensive. theScreener believes that the gain of a star(s) and an improvement in the market risk perception allows upgrading the general evaluation to Slightly Positive. As of the analysis date March 1, 2022, the closing price was USD 219.43 and i...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.